512 related items for PubMed ID: 10804944
21. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty.
Wehkalampi K, Vangonen K, Laine T, Dunkel L.
Horm Res; 2007; 68(2):99-104. PubMed ID: 17377395
[Abstract] [Full Text] [Related]
22. Growth and sexual maturation of Brazilian patients with sickle cell diseases.
Zago MA, Kerbauy J, Souza HM, Figueiredo MS, Costa FF, Cruz SM, Braga JA, Alvarenga D, Ribeiro JU, Tone LG.
Trop Geogr Med; 1992 Oct; 44(4):317-21. PubMed ID: 1295140
[Abstract] [Full Text] [Related]
23. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
Binder G, Iliev DI, Mullis PE, Ranke MB.
Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
[Abstract] [Full Text] [Related]
24. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
Pastores GM, Elstein D, Hrebícek M, Zimran A.
Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
[Abstract] [Full Text] [Related]
25. [Phenotype and mutational spectrum in Tunisian pediatric gaucher disease].
Ben Turkia H, Riahi I, Azzouz H, Ladab S, Cherif W, Ben Chehida A, Abdelmoula MS, Caillaud C, Chemli J, Abdelhak S, Tebib N, Ben Dridi MF.
Tunis Med; 2010 Mar; 88(3):158-62. PubMed ID: 20415187
[Abstract] [Full Text] [Related]
26. [The delay of bone maturation is a favorable element in the prognosis of final height].
Rochiccioli P, Tock Mine YY, Enjaume C, Dutau G, Sablayrolles B.
Arch Fr Pediatr; 1985 Apr; 42(4):273-6. PubMed ID: 4004488
[Abstract] [Full Text] [Related]
27. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H.
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[Abstract] [Full Text] [Related]
28. Coagulation abnormalities in type 1 Gaucher disease in children.
Deghady A, Marzouk I, El-Shayeb A, Wali Y.
Pediatr Hematol Oncol; 2006 Feb; 23(5):411-7. PubMed ID: 16728361
[Abstract] [Full Text] [Related]
29. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
Drelichman G, Ponce E, Basack N, Freigeiro D, Aversa L, Graciela E, Kohan R.
J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
[Abstract] [Full Text] [Related]
30. Age of pubertal onset affects the intensity and duration of pubertal growth peak but not final height.
Vizmanos B, Martí-Henneberg C, Clivillé R, Moreno A, Fernández-Ballart J.
Am J Hum Biol; 2001 Aug; 13(3):409-16. PubMed ID: 11460907
[Abstract] [Full Text] [Related]
31. Growth and pubertal delay in patients with epidermolysis bullosa.
Martinez AE, Allgrove J, Brain C.
Dermatol Clin; 2010 Apr; 28(2):357-9, xii. PubMed ID: 20447503
[Abstract] [Full Text] [Related]
32. [Growth and endocrine function in major thalassemia].
Pérignon F, Brauner R, Souberbielle JC, de Montalembert M, Girot R.
Arch Fr Pediatr; 1993 Oct; 50(8):657-63. PubMed ID: 8002739
[Abstract] [Full Text] [Related]
33. Growth and final height of children with Gaucher disease: A 15-year follow-up at an Israeli Gaucher center.
Mendelsohn E, Meir A, Abrahamov A, Elstein D, Zimran A, Levy-Khademi F.
Blood Cells Mol Dis; 2018 Feb; 68():97-99. PubMed ID: 27993449
[Abstract] [Full Text] [Related]
34. A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus.
Rygg M, Pistorio A, Ravelli A, Maghnie M, Di Iorgi N, Bader-Meunier B, Da Silva C, Roldan-Molina R, Barash J, Dracou C, Laloum SG, Jarosova K, Deslandre CJ, Koné-Paut I, Garofalo F, Press J, Sengler C, Tauber T, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO).
Ann Rheum Dis; 2012 Apr; 71(4):511-7. PubMed ID: 21998114
[Abstract] [Full Text] [Related]
35. Growth and pubertal assessment after treatment in acute leukemia.
Loke KY, Lee BW, Quah TC, Lam SK, Tay JS.
J Singapore Paediatr Soc; 1992 Apr; 34(1-2):49-52. PubMed ID: 1303467
[Abstract] [Full Text] [Related]
36. [Puberty in congenital hypothyroidism (author's transl)].
David M, Augay C, Sempé M, Pavía C, Biron A, Jeune M.
An Esp Pediatr; 1980 Sep; 13(9):771-8. PubMed ID: 7469193
[Abstract] [Full Text] [Related]
37. [Effect of hematologic treatment on the growth and puberty of children with thalassemia major].
Pomarède R, Girot R, Constant S, Rappaport R.
Arch Fr Pediatr; 1984 Apr; 41(4):255-9. PubMed ID: 6477042
[Abstract] [Full Text] [Related]
38. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.
Boomsma JM, van Dussen L, Wiersma MG, Groener JE, Aerts JM, Maas M, Hollak CE.
Blood Cells Mol Dis; 2010 Mar 15; 44(3):181-7. PubMed ID: 20074983
[Abstract] [Full Text] [Related]
39. Matched unrelated bone marrow transplantation without splenectomy for a child with Gaucher disease caused by homozygosity of the L444P mutation, who also suffered from schizencephaly.
Chen RL, Hou JW, Chang PY, Tsai FJ, Wang PJ.
J Pediatr Hematol Oncol; 2007 Jan 15; 29(1):57-9. PubMed ID: 17230068
[Abstract] [Full Text] [Related]
40. Outcome of early-treated type III Gaucher disease patients.
Lee NC, Chien YH, Wong SL, Sheen JM, Tsai FJ, Peng SF, Leung JH, Chao MC, Shun CT, Hwu WL.
Blood Cells Mol Dis; 2014 Sep 15; 53(3):105-9. PubMed ID: 24984925
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
